Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma
Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been triall...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/9/9/2969 |
| _version_ | 1797553716065206272 |
|---|---|
| author | Fiona A Lynch Lynda Katona Michael Jefford Allan Ben Smith Joanne Shaw Haryana M Dhillon Steve Ellen Jo Phipps-Nelson Julia Lai-Kwon Donna Milne Lahiru Russell Victoria Dax Justine Diggens Holly Kent Alison Button-Sloan Jane Elliott Mark Shackleton Hayley Burridge Maria Ftanou |
| author_facet | Fiona A Lynch Lynda Katona Michael Jefford Allan Ben Smith Joanne Shaw Haryana M Dhillon Steve Ellen Jo Phipps-Nelson Julia Lai-Kwon Donna Milne Lahiru Russell Victoria Dax Justine Diggens Holly Kent Alison Button-Sloan Jane Elliott Mark Shackleton Hayley Burridge Maria Ftanou |
| author_sort | Fiona A Lynch |
| collection | DOAJ |
| description | Immunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of <i>Fear-Less</i>: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, <i>Conquer Fear</i>. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that <i>Fear-Less</i> was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of <i>Fear-Less</i> in reducing FCR. <i>Fear-Less</i> is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease. |
| first_indexed | 2024-03-10T16:20:33Z |
| format | Article |
| id | doaj.art-599becb958144929b9dbf2441c28bd40 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-10T16:20:33Z |
| publishDate | 2020-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-599becb958144929b9dbf2441c28bd402023-11-20T13:42:16ZengMDPI AGJournal of Clinical Medicine2077-03832020-09-0199296910.3390/jcm9092969Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic MelanomaFiona A Lynch0Lynda Katona1Michael Jefford2Allan Ben Smith3Joanne Shaw4Haryana M Dhillon5Steve Ellen6Jo Phipps-Nelson7Julia Lai-Kwon8Donna Milne9Lahiru Russell10Victoria Dax11Justine Diggens12Holly Kent13Alison Button-Sloan14Jane Elliott15Mark Shackleton16Hayley Burridge17Maria Ftanou18Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaDepartment of Psychology and Consultation Liaison Psychiatry, Alfred Health, Melbourne, VIC 3004, AustraliaDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaCentre for Oncology Education and Research Translation, Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Kensington, NSW 2052, AustraliaPsycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, The University of Sydney, Sydney, NSW 2006, AustraliaPsycho-Oncology Co-operative Research Group (PoCoG), School of Psychology, The University of Sydney, Sydney, NSW 2006, AustraliaPsychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaSir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3010, AustraliaDepartment of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaHealth Services and Implementation Science, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaSchool of Nursing and Midwifery, Institute for Health Transformation, Deakin University, Geelong, VIC 3217, AustraliaPsychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaPsychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaDepartment of Psychology and Consultation Liaison Psychiatry, Alfred Health, Melbourne, VIC 3004, AustraliaMelanoma Patients Australia, Melbourne, VIC 3000, AustraliaPsychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaDepartment of Medical Oncology, Alfred Health, Melbourne, VIC 3004, AustraliaDepartment of Medical Oncology, Alfred Health, Melbourne, VIC 3004, AustraliaPsychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, VIC 3000, AustraliaImmunotherapies and targeted therapies have revolutionised treatment of metastatic melanoma and improved survival rates. However, survivors treated with novel therapies are vulnerable to high levels of fear of cancer recurrence or progression (FCR). Existing FCR interventions have rarely been trialled in people with advanced cancer. The current study aimed to evaluate the acceptability and feasibility of <i>Fear-Less</i>: a stepped-care model to treat FCR in people with metastatic melanoma treated with immunotherapy or targeted therapy. Sixty-one outpatients with metastatic melanoma were screened using the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) and Fear of Progression Questionnaire Short Form (FoP-Q-SF). Survivors with subthreshold FCR were stratified to a self-management intervention while those with clinical levels of FCR were provided with an individual therapy, <i>Conquer Fear</i>. Survivor experience surveys and rescreening were administered post-intervention completion. Results indicated that <i>Fear-Less</i> was an acceptable and feasible FCR intervention. Results provided preliminary support for the potential impact of <i>Fear-Less</i> in reducing FCR. <i>Fear-Less</i> is a promising first step in providing an acceptable and feasible stepped-care model to treat FCR in survivors with metastatic disease.https://www.mdpi.com/2077-0383/9/9/2969fear of cancer recurrencestepped caremetastatic melanoma |
| spellingShingle | Fiona A Lynch Lynda Katona Michael Jefford Allan Ben Smith Joanne Shaw Haryana M Dhillon Steve Ellen Jo Phipps-Nelson Julia Lai-Kwon Donna Milne Lahiru Russell Victoria Dax Justine Diggens Holly Kent Alison Button-Sloan Jane Elliott Mark Shackleton Hayley Burridge Maria Ftanou Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma Journal of Clinical Medicine fear of cancer recurrence stepped care metastatic melanoma |
| title | Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
| title_full | Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
| title_fullStr | Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
| title_full_unstemmed | Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
| title_short | Feasibility and Acceptability of <i>Fear-Less</i>: A Stepped-Care Program to Manage Fear of Cancer Recurrence in People with Metastatic Melanoma |
| title_sort | feasibility and acceptability of i fear less i a stepped care program to manage fear of cancer recurrence in people with metastatic melanoma |
| topic | fear of cancer recurrence stepped care metastatic melanoma |
| url | https://www.mdpi.com/2077-0383/9/9/2969 |
| work_keys_str_mv | AT fionaalynch feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT lyndakatona feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT michaeljefford feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT allanbensmith feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT joanneshaw feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT haryanamdhillon feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT steveellen feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT jophippsnelson feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT julialaikwon feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT donnamilne feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT lahirurussell feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT victoriadax feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT justinediggens feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT hollykent feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT alisonbuttonsloan feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT janeelliott feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT markshackleton feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT hayleyburridge feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma AT mariaftanou feasibilityandacceptabilityofifearlessiasteppedcareprogramtomanagefearofcancerrecurrenceinpeoplewithmetastaticmelanoma |